Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.23p
   
  • Change Today:
    -0.090p
  • 52 Week High: 3.35
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 144,158
  • Market Cap: £9.29m
  • RiskGrade: 328

Regulatory News

Holding(s) in Company 06-Jun-2024 16:20 RNS
Notice of AGM & Annual Report & Accounts 05-Jun-2024 14:01 RNS
Final Results 05-Jun-2024 07:00 RNS
Realisation-c£1.5m on sale of shares in Inc... 03-Jun-2024 10:09 RNS
Holding(s) in Company 03-May-2024 07:00 RNS
Grant of Share Options 19-Apr-2024 07:00 RNS
New intellectual property strategy initiated 02-Apr-2024 07:03 RNS
Incanthera provides Comm'l Update/Revenue F'casts 25-Mar-2024 07:25 RNS
Grant of Share Options 19-Mar-2024 07:00 RNS
Financial, Business and Portfolio Develop't Update 06-Mar-2024 07:00 RNS
Holding(s) in Company 28-Dec-2023 13:35 RNS
Holding(s) in Company 19-Dec-2023 14:50 RNS
Simbec-Orion appointed as CRO 19-Dec-2023 07:00 RNS
Incanthera - Comm'l Skincare Deal/£1M... 18-Dec-2023 07:15 RNS
Holding(s) in Company 13-Sep-2023 15:47 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.23p
Change Today -0.090p
% Change -3.88 %
52 Week High 3.35
52 Week Low 0.85
Volume 144,158
Shares Issued 416.44m
Market Cap £9.29m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.89% below the market average72.89% below the market average72.89% below the market average72.89% below the market average72.89% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average
Price Trend
28.8% below the market average28.8% below the market average28.8% below the market average28.8% below the market average28.8% below the market average
13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:51 4,500 @ 2.21p
15:49 90,000 @ 2.24p
15:48 100 @ 2.17p
09:42 211 @ 2.36p
09:15 15,378 @ 2.30p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page